FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. “I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U.S. All rights reserved.
Let's personalize your content